Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women
- 1 May 1995
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 63 (5) , 1027-1031
- https://doi.org/10.1016/s0015-0282(16)57542-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1993
- Amelioration of Insulin Resistance in Diabetes With DehydroepiandrosteroneThe Lancet Healthy Longevity, 1993
- Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cellsClinical Immunology and Immunopathology, 1991
- Opposing Actions of Dehydroepiandrosterone and Testosterone on Insulin Sensitivity: In Vivo and In Vitro Studies of Hyperandrogenic FemalesDiabetes, 1991
- Effect of Menopause and Hormone Replacement Therapy on the Urinary Excretion of Pyridinium Cross-LinksJournal of Clinical Endocrinology & Metabolism, 1991
- Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopauseMaturitas, 1989
- Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosteroneAdvances in Enzyme Regulation, 1987
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Phytohemagglutini (PHA) activated human T-lymphocytes: Concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH)Biochemical and Biophysical Research Communications, 1986
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985